Immunotherapy drug which could stall lung cancer for up to five years will now be funded by the NHS 

Health Daily Mail

The injectable cancer drug Imfinzi, pharmaceutical name durvalumab, will be available on the NHS from today in what has been called a 'watershed moment' for patients with some types of lung cancer. …

Read more »

Related Stories

AI spotted lung cancer BETTER than expert radiologists, study finds 

20/05/2019 • 15:05 Health Daily Mail

'Please don't let us die': Three cystic fibrosis sufferers beg the NHS to fund 'wonder drug'

17/05/2019 • 09:02 Health Daily Mail

NHS to fund drug that prolongs lives of children with muscle-wasting disease

15/05/2019 • 05:30 UK The Guardian

NHS compensation payouts for injuries and misdiagnosis double in five years

13/05/2019 • 11:25 The Independent

Google says its AI can spot lung cancer a year before doctors

7/05/2019 • 19:55 Tech The Telegraph

NHS will recruit tens of thousands of foreign nurses over next five years

7/05/2019 • 07:41 Daily Mail

More than 2,500 prison staff disciplined in five years with majority for sex and drugs, MoJ figures show

29/04/2019 • 20:43 Environment The Telegraph

6,000 non-smokers die of lung cancer every year, warn Public Health England 

25/04/2019 • 23:05 The Telegraph

Five years ago Tory panic pushed Nigel Farage to victory in Europe – now they're rolling out the red carpet again

24/04/2019 • 12:52 Video The Independent

New lung cancer drug combination treats up to 25% of resistant cases

31/03/2019 • 15:02 Health Daily Mail